Toll Free: 1-888-928-9744

Spectrum Pharmaceuticals, Inc. - Product Pipeline Review - 2016

Published: Apr 20, 2016 | Pages: 81 | Publisher: Global Markets Direct | Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

Spectrum Pharmaceuticals, Inc. - Product Pipeline Review - 2016

Summary

Global Markets Direct's, 'Spectrum Pharmaceuticals, Inc. - Product Pipeline Review - 2016', provides an overview of the Spectrum Pharmaceuticals, Inc.'s pharmaceutical research and development focus. 

The report provides comprehensive information on the therapeutics under development by Spectrum Pharmaceuticals, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of Spectrum Pharmaceuticals, Inc.
- The report provides overview of Spectrum Pharmaceuticals, Inc. including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities 
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages 
- The report assesses Spectrum Pharmaceuticals, Inc.'s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type 
- The report features Spectrum Pharmaceuticals, Inc.'s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons To Buy

- Evaluate Spectrum Pharmaceuticals, Inc.'s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage 
- Identify and understand important and diverse types of therapeutics under development for Spectrum Pharmaceuticals, Inc.
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Spectrum Pharmaceuticals, Inc.'s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope 
 Table of Contents
Table of Content 2 List of Tables 5 List of Figures 5 Spectrum Pharmaceuticals, Inc. Snapshot 6 Spectrum Pharmaceuticals, Inc. Overview 6 Key Information 6 Key Facts 6 Spectrum Pharmaceuticals, Inc. - Research and Development Overview 7 Key Therapeutic Areas 7 Spectrum Pharmaceuticals, Inc. - Pipeline Review 10 Pipeline Products by Stage of Development 10 Pipeline Products - Monotherapy 11 Pipeline Products - Partnered Products 12 Partnered Products/Combination Treatment Modalities 13 Spectrum Pharmaceuticals, Inc. - Pipeline Products Glance 14 Spectrum Pharmaceuticals, Inc. - Late Stage Pipeline Products 14 Pre-Registration Products/Combination Treatment Modalities 14 Phase III Products/Combination Treatment Modalities 15 Spectrum Pharmaceuticals, Inc. - Clinical Stage Pipeline Products 16 Phase II Products/Combination Treatment Modalities 16 Phase I Products/Combination Treatment Modalities 17 Spectrum Pharmaceuticals, Inc. - Early Stage Pipeline Products 18 Preclinical Products/Combination Treatment Modalities 18 Spectrum Pharmaceuticals, Inc. - Unknown Stage Pipeline Products 19 Unknown Products/Combination Treatment Modalities 19 Spectrum Pharmaceuticals, Inc. - Drug Profiles 20 apaziquone 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 vincristine sulfate 22 Product Description 22 Mechanism of Action 22 R&D Progress 22 eflapegrastim 25 Product Description 25 Mechanism of Action 25 R&D Progress 25 belinostat 26 Product Description 26 Mechanism of Action 26 R&D Progress 26 menadione sodium bisulfite 29 Product Description 29 Mechanism of Action 29 R&D Progress 29 ozarelix 31 Product Description 31 Mechanism of Action 31 R&D Progress 31 poziotinib 33 Product Description 33 Mechanism of Action 33 R&D Progress 33 pralatrexate 35 Product Description 35 Mechanism of Action 35 R&D Progress 35 SPI-014 38 Product Description 38 Mechanism of Action 38 R&D Progress 38 SPI-1620 39 Product Description 39 Mechanism of Action 39 R&D Progress 39 Alocrest 41 Product Description 41 Mechanism of Action 41 R&D Progress 41 MTRN-2696 43 Product Description 43 Mechanism of Action 43 R&D Progress 43 SPI-205 44 Product Description 44 Mechanism of Action 44 R&D Progress 44 topotecan hydrochloride 45 Product Description 45 Mechanism of Action 45 R&D Progress 45 melphalan 46 Product Description 46 Mechanism of Action 46 R&D Progress 46 Yttritum 90 ibritumomab tiuxetan 47 Product Description 47 Mechanism of Action 47 R&D Progress 47 Spectrum Pharmaceuticals, Inc. - Pipeline Analysis 49 Spectrum Pharmaceuticals, Inc. - Pipeline Products by Target 49 Spectrum Pharmaceuticals, Inc. - Pipeline Products by Route of Administration 51 Spectrum Pharmaceuticals, Inc. - Pipeline Products by Molecule Type 52 Spectrum Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action 53 Spectrum Pharmaceuticals, Inc. - Recent Pipeline Updates 55 Spectrum Pharmaceuticals, Inc. - Dormant Projects 76 Spectrum Pharmaceuticals, Inc. - Discontinued Pipeline Products 77 Discontinued Pipeline Product Profiles 77 efaproxiral 77 ortataxel 77 RH-1 77 Spectrum Pharmaceuticals, Inc. - Company Statement 78 Spectrum Pharmaceuticals, Inc. - Locations And Subsidiaries 79 Head Office 79 Other Locations & Subsidiaries 79 Appendix 80 Methodology 80 Coverage 80 Secondary Research 80 Primary Research 80 Expert Panel Validation 80 Contact Us 80 Disclaimer 81
List of Tables
Spectrum Pharmaceuticals, Inc., Key Information 6 Spectrum Pharmaceuticals, Inc., Key Facts 6 Spectrum Pharmaceuticals, Inc. - Pipeline by Indication, 2016 8 Spectrum Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2016 10 Spectrum Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2016 11 Spectrum Pharmaceuticals, Inc. - Partnered Products in Pipeline, 2016 12 Spectrum Pharmaceuticals, Inc. - Partnered Products/ Combination Treatment Modalities, 2016 13 Spectrum Pharmaceuticals, Inc. - Pre-Registration, 2016 14 Spectrum Pharmaceuticals, Inc. - Phase III, 2016 15 Spectrum Pharmaceuticals, Inc. - Phase II, 2016 16 Spectrum Pharmaceuticals, Inc. - Phase I, 2016 17 Spectrum Pharmaceuticals, Inc. - Preclinical, 2016 18 Spectrum Pharmaceuticals, Inc. - Unknown, 2016 19 Spectrum Pharmaceuticals, Inc. - Pipeline by Target, 2016 49 Spectrum Pharmaceuticals, Inc. - Pipeline by Route of Administration, 2016 51 Spectrum Pharmaceuticals, Inc. - Pipeline by Molecule Type, 2016 52 Spectrum Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action, 2016 54 Spectrum Pharmaceuticals, Inc. - Recent Pipeline Updates, 2016 55 Spectrum Pharmaceuticals, Inc. - Dormant Developmental Projects,2016 76 Spectrum Pharmaceuticals, Inc. - Discontinued Pipeline Products, 2016 77 Spectrum Pharmaceuticals, Inc., Other Locations 79 Spectrum Pharmaceuticals, Inc., Subsidiaries 79


List of Figures
Spectrum Pharmaceuticals, Inc. - Pipeline by Top 10 Indication, 2016 8 Spectrum Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2016 10 Spectrum Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2016 11 Spectrum Pharmaceuticals, Inc. - Partnered Products in Pipeline, 2016 12 Spectrum Pharmaceuticals, Inc. - Pipeline by Top 10 Target, 2016 49 Spectrum Pharmaceuticals, Inc. - Pipeline by Route of Administration, 2016 51 Spectrum Pharmaceuticals, Inc. - Pipeline by Molecule Type, 2016 52 Spectrum Pharmaceuticals, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2016 53

To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global advanced energy storage systems market size is anticipated to be valued at USD 24.8 billion by 2022, as per a new research report by Radiant Insights, Inc. Increasing energy consumption coupled with strong energy demand for industrial, commerc

Read More...

Global agricultural films market size is anticipated to reach USD 10.5 billion by 2020, as per a new research report by Radiant Insights, Inc. Increasing need to raise agricultural productivity, in order to meet surplus demand by growing population i

Read More...

Global heat transfer fluids market size is likely to be valued at USD 3.7 billion by 2020; as per a new research report by Radiant Insights, Inc. Increasing demand for for heat recovery management in industries such as metal processing, pharmaceutica

Read More...

Global data center UPS market size is estimated to reach USD 5.7 billion by 2020, as per a new research report by Radiant Insights, Inc. Declining tolerance levels pertaining to data loss along with amplifying acceptance of cloud computing is likely

Read More...

Global alpha olefins market size is likely to be valued at USD 10.7 billion by 2020; as per a new research report by Radiant Insights, Inc. Increasing polyethylene demand for use in plastic production is anticipated to drive market growth. Growing ap

Read More...
Choose License Type
Single User - US $1500
Multi User - US $3000
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify